成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 151096-09-2 Chemical Structure| 151096-09-2
Chemical Structure| 151096-09-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 151096-09-2

,{[proInfo.pro_purity]}

Moxifloxacin is a fourth-generation fluoroquinolone antibiotic with expanded activity against gram-positive bacteria as well as atypical pathogens.

Synonyms: BAY 12-8039 free base; BAY12-8039

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Moxifloxacin

CAS No. :151096-09-2
Formula : C21H24FN3O4
M.W : 401.43
SMILES Code : O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC)C1=O)O
Synonyms :
BAY 12-8039 free base; BAY12-8039
MDL No. :MFCD04117996
InChI Key :FABPRXSRWADJSP-MEDUHNTESA-N
Pubchem ID :152946

Safety of Moxifloxacin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H318-H411
Precautionary Statements:P280-P305+P351+P338+P310
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Target
  • Topo II

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01329250 Tuberculosis PHASE4 TERMINATED 2025-08-16 University Medical Center Gron... More >>ingen, Groningen, Netherlands Less <<
NCT01091493 Chronic Obstructive Pulmonary ... More >>Disease Less << PHASE4 COMPLETED 2018-07-05 Hospital Miquel Servet, Zarago... More >>za, Aragon, 50009, Spain|Fundacio Clinic Per la Recerca Biomèdica - Hospital Clinic de Barcelona, Barcelona, Catalonia, 08036, Spain|Fundació La Fe- Hospital La Fe, Valencia, Comunitat Valenciana, 46009, Spain|Hospital Clínica Platón, Barcelona, 08006, Spain Less <<
NCT02016157 Chronic Generalized Periodonti... More >>tis Less << PHASE4 COMPLETED 2025-11-12 Sri Hasanamba Dental College &... More >> Hospital, Hassan, Karnataka, 573201, India Less <<
NCT00082173 Tuberculosis PHASE2 COMPLETED 2025-09-08 Clementino Fraga Filho Hospita... More >>l, Rio de Janeiro, Brazil Less <<
NCT01756521 the Effect of Moxifloxacin on ... More >>QT/QTc Interval Less << PHASE1 COMPLETED 2025-10-13 Seoul National University Hosp... More >>ital, Seoul, Korea, Republic of Less <<
NCT02595359 Endophthalmitis PHASE2 COMPLETED 2018-06-20 UFPE Ophthalmology, Recife, PE... More >>, 50740600, Brazil Less <<
NCT02119091 Cardiac Toxicity PHASE1 UNKNOWN 2025-12-14 Spaulding Clinical Research LL... More >>C, West Bend, Wisconsin, 53025, United States|Peking University Third Hospital Clinical Trial Center, Beijing, Beijing, 100191, China Less <<
NCT01158755 Meningitis, Tuberculous|Pharma... More >>cokinetics|Pharmacodynamics|Tolerability Less << PHASE2 COMPLETED 2025-06-12 Hasan Sadikin General Hospital... More >>, Bandung, West Java, 40161, Indonesia Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.49mL

0.50mL

0.25mL

12.46mL

2.49mL

1.25mL

24.91mL

4.98mL

2.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories